The BMJ brings you interviews with the people who are shaping medicine and science around the world.
…
continue reading
MP3•Episode home
Manage episode 433007019 series 2310018
Content provided by Johns Hopkins Kimmel Cancer Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Johns Hopkins Kimmel Cancer Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here
120 episodes